BNP Paribas Financial Markets’s Park Ha Biological Technology Co BYAH Stock Holding History

BNP Paribas Financial Markets’s Portfolio BYAH Stock Details BYAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-241	Closed	-$421K	–	5816
2025 Q2	$421K	Buy	+241	New	+$202K	﹤0.01%	3431

Other funds holding BYAH

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets's BYAH Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Park Ha Biological Technology Co (BYAH) in Q3 2025, closing a stake of 241 shares — an estimated $421K sold.

BNP Paribas Financial Markets first reported a position in BYAH in Q2 2025 and held it in 1 quarter. The position peaked at $421K in Q2 2025. 6 funds tracked by Wall St. Rank hold BYAH as of Q3 2025.

BNP Paribas Financial Markets reported no remaining Park Ha Biological Technology Co position as of Q3 2025 after selling out during the quarter.
BNP Paribas Financial Markets sold 241 Park Ha Biological Technology Co shares in Q3 2025, an estimated $421K.
BNP Paribas Financial Markets first reported a position in Park Ha Biological Technology Co in Q2 2025 and held it in 1 quarter.
BNP Paribas Financial Markets's Park Ha Biological Technology Co position peaked at $421K in Q2 2025.
6 funds tracked by Wall St. Rank held Park Ha Biological Technology Co as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.